The Hindu Businessline
Elections 2026Business / The Hindu Businessline
Biocons Pebrilzo becomes first biosimilar approved under EMAs tailored clinical pathway
18 Nov 2026 10:15 am
27 C
Biocons Pebrilzo becomes first biosimilar approved under EMAs tailored clinical pathway